Fluvoxamino acid is the major metabolite of Fluvoxamine ( HY-B0103 ) produced in the human body, and acts as a 5-HT reuptake transporter inhibitor. Fluvoxamino acid exhibits weaker inhibitory activity against 5-HT reuptake than its parent compound Fluvoxamine , and can synergistically regulate 5-HT transmission with the parent compound. Fluvoxamino acid can be used in the research of major depressive disorder.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Depression | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Drug Metabolite | Products > Signaling Pathways > 5-HT Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye